Go to deals
Healthcare

Grupo Auguri has acquired a controlling interest in Clínica Las Condes S.A.

Grupo Auguri has acquired a controlling interest in Clínica Las Condes S.A.

Grupo Auguri is a Chilean family office linked to the Karlezi Solari family, which have investments in multiple companies from various industries throughout the country and abroad.

Based in Santiago, Clínica Las Condes is one of the largest private hospitals in Chile. The company initiated its operations in 1982 with a focus on high complexity medicine. Its services include inpatient medical, surgical intensive care units, intermediate, adult, pediatric, neonatal, surgical wards, post-recovery operative, clinical laboratories, radiology, CT magnetic resonance imaging, radiation therapy, PET-CT, nuclear medicine, ultrasound, dialysis and other services that include outpatient procedures.

Oaklins’ team in Chile acted as financial advisor to Grupo Auguri in this transaction.

Service
M&A buy-side
Parties

Talk to the deal team

 Raimundo  Silva

Raimundo Silva

Partner

Santiago, Chile
Oaklins LarrainVial
 Alberto  del Pedregal

Alberto del Pedregal

Associate

Santiago, Chile
Oaklins LarrainVial

Related deals

Gilde Healthcare has invested in Tandarts Today
Private Equity | Healthcare

Gilde Healthcare has invested in Tandarts Today

Gilde Healthcare has invested in Tandarts Today, a fast-growing dental chain in the Netherlands. The investment will allow Tandarts Today to accelerate its buy-and-build strategy and become a leading dental chain in the Netherlands. Financial details have not been disclosed.

Learn more
Alcidion (ASX:ALC) has acquired ExtraMed
Healthcare

Alcidion (ASX:ALC) has acquired ExtraMed

Alcidion (ASX:ALC) has acquired ExtraMed Ltd., a UK provider of patient flow management software that helps address key pain-points for hospital administrative staff.

Learn more
Alcidion (ASX:ALC) has completed a capital raise
Healthcare

Alcidion (ASX:ALC) has completed a capital raise

Alcidion (ASX:ALC) has raised funds to continue its growth strategy.

Learn more